Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s stock price traded down 3.1% during mid-day trading on Tuesday . The stock traded as low as $60.83 and last traded at $61.53. 6,487,628 shares changed hands during mid-day trading, a decline of 4% from the average session volume of 6,782,815 shares. The stock had previously closed at $63.47.
Wall Street Analyst Weigh In
Several brokerages have recently commented on TEM. Guggenheim reiterated a "buy" rating on shares of Tempus AI in a research note on Tuesday, February 25th. William Blair reaffirmed a "market perform" rating on shares of Tempus AI in a report on Tuesday, February 25th. Piper Sandler upped their price objective on shares of Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a report on Thursday, May 15th. Morgan Stanley raised their target price on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. Finally, TD Cowen reiterated a "buy" rating and issued a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Six analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Tempus AI presently has a consensus rating of "Moderate Buy" and an average target price of $63.42.
View Our Latest Analysis on TEM
Tempus AI Stock Performance
The company's 50-day moving average price is $52.78 and its two-hundred day moving average price is $51.98. The company has a market capitalization of $10.87 billion and a price-to-earnings ratio of -8.05. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.
Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.03. The business had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. The company's quarterly revenue was up 75.4% on a year-over-year basis. On average, equities research analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.
Insider Activity
In related news, EVP Andrew Polovin sold 13,135 shares of the company's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $45.98, for a total value of $603,947.30. Following the sale, the executive vice president now owns 154,171 shares in the company, valued at $7,088,782.58. This represents a 7.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO James William Rogers sold 23,030 shares of the firm's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $45.97, for a total transaction of $1,058,689.10. Following the completion of the transaction, the chief financial officer now directly owns 164,750 shares in the company, valued at approximately $7,573,557.50. The trade was a 12.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 139,888 shares of company stock worth $7,938,111 in the last three months. Company insiders own 27.60% of the company's stock.
Institutional Trading of Tempus AI
Several institutional investors and hedge funds have recently modified their holdings of TEM. First Horizon Advisors Inc. raised its position in Tempus AI by 12.7% in the 1st quarter. First Horizon Advisors Inc. now owns 1,849 shares of the company's stock valued at $89,000 after buying an additional 208 shares during the last quarter. Wells Fargo & Company MN raised its holdings in shares of Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock valued at $80,000 after purchasing an additional 278 shares during the last quarter. Bartlett & CO. Wealth Management LLC lifted its position in shares of Tempus AI by 100.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after purchasing an additional 400 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Tempus AI by 10.1% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,594 shares of the company's stock worth $268,000 after purchasing an additional 515 shares during the last quarter. Finally, Cherry Tree Wealth Management LLC purchased a new position in Tempus AI during the first quarter worth about $31,000. 24.22% of the stock is owned by hedge funds and other institutional investors.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
